Epidemiology of Healthcare-Associated Pneumonia (HCAP)

Seminars in Respiratory and Critical Care Medicine

Volumn 30, Issue 1, 2009, Pages 10-15

  Zilberberg, Marya D ^a,b   Shorr, Andrew F ^c,d  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b EviMed Research Group LLC   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Health care associated; Methicillin resistant; Pneumonia; Staphylococcus aureus

Indexed keywords

BACTERIOLOGY; COMMUNITY ACQUIRED PNEUMONIA; ECONOMIC ASPECT; HEALTH CARE UTILIZATION; HEALTHCARE ASSOCIATED PNEUMONIA; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; INFECTIOUS PNEUMONIA; INTENSIVE CARE UNIT; LENGTH OF STAY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NURSING HOME; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; STREPTOCOCCUS PNEUMONIAE;

COST OF ILLNESS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 60549093576     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0028-1119804     Document Type: Review

References (20)

1. Hospital-Acquired Pneumonia Guideline Committee of the American Thoracic Society and Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired pneumonia, ventilator-associated pneumonia, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416
2. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005;128:3854-3862
3. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122:262-268
4. Alvarez-Lerma FICU-acquired Pneumonia Study Group. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 1996;22:387-394
5. Micek ST, Kollef KE, Reichley RM, et al. Healthcare- associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007;51:3568-3573
6. Carratala J, Mykietiuk A, Fernandez-Sabe N, et al. Healthcare-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy and clinical outcomes. Arch Intern Med 2007;167:1393-1399
7. Shorr AF, Zilberberg MD, Micek ST, et al. Healthcare- associated pneumonia: a valuable concept at predicting resistant infections? Arch Intern Med 2008; In press
8. Zilberberg MD, Shorr AF, Micek ST, Mody SH, Kollef MH. Antimicrobial therapy escalation and hospital mortality among patients with HCAP: A single center experience. Chest 2008 Jul 18 [Epub ahead of print]
9. Morin CA, Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 2001;184:1029-1034
10. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791-797
11. Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 2002;34:1431-1439
12. McDonald JR, Friedman ND, Stout JE, et al. Risk factors for ineffective therapy in patients with bloodstream infections. Arch Intern Med 2005;165:308-313
13. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-2984
14. Tambyah PA, Habib AG, Ng TM, et al. Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually ''healthcare associated.'' Infect Control Hosp Epidemiol 2003;24:436-438
15. Shorr AF, Tabak YP, Killian AD, et al. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large US database. Crit Care Med 2006;34:2588-2595
16. Shorr AF, Micek ST, Jackson WL, et al. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Crit Care Med 2007;35: 1257-1262
17. Shorr AF, Micek ST, Kollef MH. Inappropriate therapy for methicillin-resistant Staphylococcus aureus: resource utilization and cost implications. Crit Care Med 2008;36:2335-2340
18. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin- resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666-674
19. Centers for Disease Control and Prevention. Severe Clostri- dium difficile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep 2005;54:1201-1205
20. Centers for Disease Control and Prevention. Surveillance for community-associated Clostridium difficile-Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008;57:340-343